Our study, to the best of our knowledge, is the first description that PD-L1 expression in multiple myeloma patient bone marrow is a dynamic process and this dynamic change of PD-L1 expression may have prognostic significance. The gene discussed is CD274; the disease is plasma cell myeloma.